Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1985 1
1991 2
1992 1
1993 2
1999 2
2000 3
2001 3
2004 3
2005 1
2007 2
2008 1
2009 1
2010 4
2011 2
2012 4
2013 8
2014 8
2015 8
2016 3
2017 8
2018 11
2019 14
2020 11
2021 5
2022 14
2023 4
2024 10
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Senescence-associated reprogramming promotes cancer stemness.
Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, Dörken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, Schmitt CA. Milanovic M, et al. Among authors: metzner m. Nature. 2018 Jan 4;553(7686):96-100. doi: 10.1038/nature25167. Epub 2017 Dec 20. Nature. 2018. PMID: 29258294
Melanonychia.
Metzner MJ, Billington AR, Payne WG. Metzner MJ, et al. Eplasty. 2015 Aug 20;15:ic48. eCollection 2015. Eplasty. 2015. PMID: 26335443 Free PMC article. No abstract available.
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Jakobsen NA, Turkalj S, Zeng AGX, Stoilova B, Metzner M, Rahmig S, Nagree MS, Shah S, Moore R, Usukhbayar B, Angulo Salazar M, Gafencu GA, Kennedy A, Newman S, Kendrick BJL, Taylor AH, Afinowi-Luitz R, Gundle R, Watkins B, Wheway K, Beazley D, Murison A, Aguilar-Navarro AG, Flores-Figueroa E, Dakin SG, Carr AJ, Nerlov C, Dick JE, Xie SZ, Vyas P. Jakobsen NA, et al. Among authors: metzner m. Cell Stem Cell. 2024 Aug 1;31(8):1127-1144.e17. doi: 10.1016/j.stem.2024.05.010. Epub 2024 Jun 24. Cell Stem Cell. 2024. PMID: 38917807 Free PMC article.
Outcomes of a Delirium Prevention Program in Older Persons After Elective Surgery: A Stepped-Wedge Cluster Randomized Clinical Trial.
Deeken F, Sánchez A, Rapp MA, Denkinger M, Brefka S, Spank J, Bruns C, von Arnim CAF, Küster OC, Conzelmann LO, Metz BR, Maurer C, Skrobik Y, Forkavets O, Eschweiler GW, Thomas C; PAWEL Study Group. Deeken F, et al. JAMA Surg. 2022 Feb 1;157(2):e216370. doi: 10.1001/jamasurg.2021.6370. Epub 2022 Feb 9. JAMA Surg. 2022. PMID: 34910080 Free PMC article. Clinical Trial.
Risk Stratification in Older Intensively Treated Patients With AML.
Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen NA, Kennedy A, Moore R, Boertjes E, Vonk CM, Kavelaars FG, Rijken M, Gilkes A, Schwab C, Beverloo HB, Manz M, Visser O, Van Elssen CHMJ, de Weerdt O, Tick LW, Biemond BJ, Vekemans MC, Freeman SD, Harrison CJ, Cook JA, Dennis M, Knapper S, Thomas I, Craddock C, Ossenkoppele GJ, Löwenberg B, Russell N, Valk PJM, Vyas P. Versluis J, et al. Among authors: metzner m. J Clin Oncol. 2024 Dec;42(34):4084-4094. doi: 10.1200/JCO.23.02631. Epub 2024 Sep 4. J Clin Oncol. 2024. PMID: 39231389 Free PMC article.
Mass Immunizations: A Pocket Guide.
Rice K, Backer H, McFadden H, Bode J, Metzner M, Noste E, Devereaux AV. Rice K, et al. Among authors: metzner m. Disaster Med Public Health Prep. 2023 Apr 17;17:e379. doi: 10.1017/dmp.2023.37. Disaster Med Public Health Prep. 2023. PMID: 37066761 Review.
Detecting and quantifying clonal selection in somatic stem cells.
Körber V, Jakobsen NA, Ansari-Pour N, Moore R, Claudino N, Metzner M, Thielecke E, Esau F, Usukhbayar B, Salazar MA, Newman S, Kendrick BJL, Taylor AH, Afinowi-Luitz R, Gundle R, Watkins B, Wheway K, Beazley D, Dakin SG, Palmer A, Carr AJ, Vyas P, Höfer T. Körber V, et al. Among authors: metzner m. Nat Genet. 2025 Jul;57(7):1718-1729. doi: 10.1038/s41588-025-02217-y. Epub 2025 Jul 3. Nat Genet. 2025. PMID: 40610627 Free PMC article.
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.
Russell NH, Thomas A, Hills RK, Thomas I, Gilkes A, Almuina NM, Burns S, Marsh L, Vyas P, Metzner M, McCarthy N, Andrew G, Byrne J, Sellar RS, Kelly R, Cahalin P, Overgaard UM, Mehta P, Dennis M, Knapper S, Freeman SD. Russell NH, et al. Among authors: metzner m. J Clin Oncol. 2025 Feb 20;43(6):694-704. doi: 10.1200/JCO.24.00259. Epub 2024 Nov 18. J Clin Oncol. 2025. PMID: 39556780 Free PMC article. Clinical Trial.
131 results